Kmart to pay $32 million to settle drug overbilling allegations
WASHINGTON (Reuters) - Kmart Corp, a unit of Sears Holdings Corp, has agreed to pay $32.3 million to settle allegations that its pharmacies failed to report discounted prescription drug prices to federal health programs, the U.S. Justice Department said on Friday.
from Reuters: Health News http://reut.rs/2ziJn8l
http://bit.ly/2zwRqiM